Evidence map›Paper›PMID 26418881›Full record

ArticleOncotarget2015

The effective bioengineering method of implantation decellularized renal extracellular matrix scaffolds.

Yong Guan, Shuangde Liu, Chao Sun, Guanghui Cheng, Feng Kong, Yun Luan, Xiaoshuai Xie, Shengtian Zhao, Denglu Zhang, Jue Wang and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Decellularized rat tubules for tissue engineering.Translational andrology and urology · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Potential Strategies for Kidney Regeneration With Stem Cells: An Overview.Frontiers in cell and developmental biology · 2022
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Mesenchymal Stem Cells-Potential Applications in Kidney Diseases.International journal of molecular sciences · 2019
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Advances in the Knowledge about Kidney Decellularization and Repopulation.Frontiers in bioengineering and biotechnology · 2017
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yong GuanDepartment of Urology, The Second Hospital, Shandong University, Shandong, China.
Shuangde LiuDepartment of Kidney Transplantation, The Second Hospital, Shandong University, Shandong, China.
Chao SunDepartment of Central Research Lab, The Second Hospital, Shandong University, Shandong, China.
Guanghui ChengDepartment of Central Research Lab, The Second Hospital, Shandong University, Shandong, China.
Feng KongDepartment of Central Research Lab, The Second Hospital, Shandong University, Shandong, China.
Yun LuanDepartment of Central Research Lab, The Second Hospital, Shandong University, Shandong, China.
Xiaoshuai XieDepartment of Urology, The Second Hospital, Shandong University, Shandong, China.
Shengtian ZhaoDepartment of Urology, The Second Hospital, Shandong University, Shandong, China.
Denglu ZhangDepartment of Urology, The Second Hospital, Shandong University, Shandong, China.
Jue WangDepartment of Central Research Lab, The Second Hospital, Shandong University, Shandong, China.
Kailin LiDepartment of Central Research Lab, The Second Hospital, Shandong University, Shandong, China.
Yuqiang LiuDepartment of Urology, The Second Hospital, Shandong University, Shandong, China.
Second Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

End stage renal disease (ESRD) is a progressive loss of kidney function with a high rate of morbidity and mortality. Transplantable organs are hard to come by and hold a high risk of recipient immune rejection. We intended to establish a more effective and faster method to decellularize and recellularize the kidney scaffold for transplant and regeneration. We successfully produced renal scaffolds by decellularizing rat kidneys with 0.5% sodium dodecyl sulfate (SDS), while still preserving the extracellular matrix (ECM) 3D architecture, an intact vascular tree and biochemical components. We recellularized the kidney scaffolds with mouse embryonic stem (ES) cells that then populated and proliferated within the glomerular, vascular, and tubular structures. After in vivo implantation, these recellularized scaffolds were easily reperfused, tolerated blood pressure and produced urine with no blood leakage. Our methods can successfully decellularize and recellularize rat kidneys to produce functional renal ECM scaffolds. These scaffolds maintain their basic components, retain intact vasculature and show promise for kidney regeneration.

Indexed as

Tissue ScaffoldsAnimalsBioengineeringExtracellular MatrixKidneyMaleRatsRats, Wistardecellularizationkidney regenerationrecellularizationscaffoldtissue engineering

Identifiers

PMID26418881
PMCPMC4742166
OpenAlexW1912419471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.